KR890003374A - 정신 분열증 치료용 약제의 제조에 2-아미노-6-(트리플루오로메톡시)벤조티아졸의 이용 - Google Patents

정신 분열증 치료용 약제의 제조에 2-아미노-6-(트리플루오로메톡시)벤조티아졸의 이용 Download PDF

Info

Publication number
KR890003374A
KR890003374A KR1019880010785A KR880010785A KR890003374A KR 890003374 A KR890003374 A KR 890003374A KR 1019880010785 A KR1019880010785 A KR 1019880010785A KR 880010785 A KR880010785 A KR 880010785A KR 890003374 A KR890003374 A KR 890003374A
Authority
KR
South Korea
Prior art keywords
schizophrenia
benzothiazole
trifluoromethoxy
amino
manufacture
Prior art date
Application number
KR1019880010785A
Other languages
English (en)
Inventor
궤레미 끌로드
마이아르 프랑소와즈
무쉬 브뤼노
Original Assignee
에르 고몽
로오느-푸우랜크 상뜨
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에르 고몽, 로오느-푸우랜크 상뜨 filed Critical 에르 고몽
Publication of KR890003374A publication Critical patent/KR890003374A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Abstract

내용 없음

Description

정신 분열증 치료용 약제의 제조에 2－아미노－6－(트리플루오로메톡시) 벤조티아졸의 이용
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (2)

  1. 정신 분열증 치료용 약제 생성물의 제조에 2－아미노－6－(트리플루오로메톡시)－벤조티아졸 또는 제약학적으로 허용가능한 이들의 염의 사용.
  2. 제 1 항에 있어서, 생성물이 정신 분열증 음성 형의 치료용인 경우에 있어서의 화합물의 사용.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019880010785A 1987-08-25 1988-08-24 정신 분열증 치료용 약제의 제조에 2-아미노-6-(트리플루오로메톡시)벤조티아졸의 이용 KR890003374A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8711882 1987-08-25
FR8711882A FR2619712B1 (fr) 1987-08-25 1987-08-25 Application de l'amino-2 trifluoromethoxy-6 benzothiazole pour obtenir un medicament destine au traitement de la schizophrenie

Publications (1)

Publication Number Publication Date
KR890003374A true KR890003374A (ko) 1989-04-14

Family

ID=9354396

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019880010785A KR890003374A (ko) 1987-08-25 1988-08-24 정신 분열증 치료용 약제의 제조에 2-아미노-6-(트리플루오로메톡시)벤조티아졸의 이용

Country Status (10)

Country Link
US (1) US4882345A (ko)
EP (1) EP0305276A3 (ko)
JP (1) JPH0196132A (ko)
KR (1) KR890003374A (ko)
AU (1) AU608048B2 (ko)
DK (1) DK473088A (ko)
FR (1) FR2619712B1 (ko)
HU (1) HUT50440A (ko)
IL (1) IL87522A0 (ko)
ZA (1) ZA886247B (ko)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2662160B1 (fr) * 1990-05-18 1992-07-24 Rhone Poulenc Sante Derives d'alkylthio-3 propyl-3 benzothiazoline leur preparation et les medicaments les contenant.
FR2662695A1 (fr) * 1990-06-05 1991-12-06 Rhone Poulenc Sante Amino-2 polyfluoroalcoxy-6 benzoselenazoles, leur preparation et les medicaments les contenant.
FR2662694A1 (fr) * 1990-06-05 1991-12-06 Rhone Poulenc Sante Derives du benzoselenazole, leur preparation et les medicaments les contenant.
FR2663030A1 (fr) * 1990-06-05 1991-12-13 Rhone Poulenc Sante Derives selenies de benzothiazoline leur preparation et les medicaments les contenant.
GB9224809D0 (en) * 1992-11-26 1993-01-13 Scotia Holdings Plc Schizophrenia
FR2787028B1 (fr) 1998-12-15 2002-10-18 Aventis Pharma Sa Utilisation du riluzole dans le traitement des traumatismes acoustiques
US6432992B1 (en) * 2000-06-05 2002-08-13 Aventis Pharm Sa Use of riluzole or its salts for the prevention and treatment of adrenoleukodystrophy
ES2819303T3 (es) * 2005-04-05 2021-04-15 Univ Yale Agentes moduladores del glutamato en el tratamiento de trastornos mentales
EP1924326B1 (en) 2005-08-25 2016-10-12 Steven Michael Weiss Reducing myocardial damage and the incidence of arrhythmia arising from loss, reduction or interruption in coronary blood flow

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2492258A1 (fr) * 1980-10-17 1982-04-23 Pharmindustrie Nouveau medicament a base d'amino-2 trifluoromethoxy-6 benzothiazole
US4826860A (en) * 1987-03-16 1989-05-02 Warner-Lambert Company Substituted 2-aminobenzothiazoles and derivatives useful as cerebrovascular agents

Also Published As

Publication number Publication date
EP0305276A3 (fr) 1990-07-25
DK473088A (da) 1989-02-26
FR2619712B1 (fr) 1990-08-31
AU608048B2 (en) 1991-03-21
DK473088D0 (da) 1988-08-24
EP0305276A2 (fr) 1989-03-01
HUT50440A (en) 1990-02-28
IL87522A0 (en) 1989-01-31
ZA886247B (en) 1989-04-26
FR2619712A1 (fr) 1989-03-03
JPH0196132A (ja) 1989-04-14
AU2143388A (en) 1989-03-02
US4882345A (en) 1989-11-21

Similar Documents

Publication Publication Date Title
KR950700060A (ko) 운동 뉴우런 질병의 치료에 유용한 약품을 얻기 위한 2-아미노-6-트리플루오로메톡시 벤조티아졸(리루졸)의 사용(Application of 2-amino 6-trifluoromethoxy benzothiazole(riluzole) for obtaining a drug useful in the treatment of motor neuron diseases)
NO870241D0 (no) Hypoglykemiske tiazolidindioner.
KR890003720A (ko) 벤조티아졸 및 그를 유효성분으로 함유하는 항류머티스제
KR920000315A (ko) 모다피닐의 용도
KR930012022A (ko) 뇌조직 보호용 모다피닐(Modafinil)
KR920019342A (ko) 골질환 치료제
KR950703953A (ko) 2-아미노-6-n-프로필아미노-4, 5, 6, 7-테트라하이드로벤조티아졸(프라미펙솔)의 항우울제로서의 용도(Use of 2-amino-6-n-propylamino-4, 5, 6, 7-tetrahydrobenzothiazole (pramipexol)as an antidepressant drug)
KR920702216A (ko) 아세틸 d-카르니틴의 녹내장 치료에의 용도
DE3587777D1 (de) Heterozyklische Verbindungen, deren Herstellung und Medikamente diese enthaltend.
KR910019620A (ko) 15-케토-프로스타글란딘 화합물을 사용한 췌장 질병의 치료
ES2078332T3 (es) Disolucion de celulosa en agua y oxido-n de metilmorfolina-n.
KR920016088A (ko) 하부 요로 질환의 치료
NL960024I2 (nl) Farmaceutisch preparaat omvattend 3'-deoxythymidine-2'-een (3'-deoxy-2',3'-didehydrothymidine) voor de behandeling van met retrovirus besmette patiënten.
KR890003374A (ko) 정신 분열증 치료용 약제의 제조에 2-아미노-6-(트리플루오로메톡시)벤조티아졸의 이용
KR910000158A (ko) 의약용 화합물 및 그것의 사용방법
KR920002151A (ko) 15-케토-프로스타글란딘 화합물에 의한 염증성 질환 치료
KR890012659A (ko) 조산아의 뇌실내 출혈방지용 치료제
KR910007531A (ko) 15-케토-프로스타글란딘 화합물을 이용한 간 담즙성 질병의 치료
KR890003373A (ko) 수면장애 및 우울증 치료에 화합물의 이용
SE8704979D0 (sv) New furanuronic acid derivatives, process for their production and their use
KR880007070A (ko) 백내장 치료용 약학 조성물
KR880009661A (ko) 궤양성 대장염치료를 위한 사람의 혈액응고인자 xiii의 용도
KR910018028A (ko) 15- 데히드록시-16-옥소프로스타글란딘 화합물에 의한 생화학적 치료
KR900017587A (ko) 바이러스 감염증 치료제의 제조를 위한 티아졸 유도체 티프로티모드의 용도
ES2049711T1 (es) Uso de bucilamina para la fabricacion de un medicamento para el tratamiento de la cistinuria.

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid